Date Filed | Type | Description |
06/28/2023 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 1,580 shares
@ $0 |
|
05/31/2023 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on ILLUMINA, INC.
Txns:
| Granted 1,532 shares
@ $0 |
|
05/25/2023 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on ILLUMINA, INC.
Txns:
| Paid exercise price by delivering 492 shares
@ $212.65, valued at
$104.6k
|
|
05/08/2023 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Duke Energy CORP
Txns:
| Granted 1,784 shares
@ $98.11, valued at
$175k
|
|
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns:
| Granted 5,197 shares
@ $0 Granted 7,688 options to buy
@ $38.49, valued at
$295.9k
|
|
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2021 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 775 shares
@ $0 |
|
06/25/2021 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns:
| Granted 2,094 shares
@ $0 Granted 3,382 options to buy
@ $83.59, valued at
$282.7k
|
|
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2021 |
4
| DORSA CAROLINE (Trustee) has filed a Form 4 on GOLDMAN SACHS MLP & ENERGY RENAISSANCE FUND |
02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2021 |
4
| DORSA CAROLINE (Trustee) has filed a Form 4 on Goldman Sachs Credit Income Fund |
09/30/2020 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Goldman Sachs MLP Income Opportunities Fund |
06/19/2020 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns:
| Granted 19,000 options to buy
@ $20.72, valued at
$393.7k
|
|
06/05/2020 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 890 shares
@ $0 |
|
05/28/2020 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on ILLUMINA, INC.
Txns:
| Paid exercise price by delivering 519 shares
@ $354.41, valued at
$183.9k
Granted 963 shares
@ $0 |
|
03/16/2020 |
3
| DORSA CAROLINE (Trustee) has filed a Form 3 on Goldman Sachs Real Estate Diversified Income Fund |
03/16/2020 |
3
| DORSA CAROLINE (Trustee) has filed a Form 3 on Goldman Sachs Credit Income Fund |
06/20/2019 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 1,155 shares
@ $0 |
|
05/30/2019 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Granted 1,298 shares
@ $0 |
|
05/28/2019 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Paid exercise price by delivering 589 shares
@ $308.97, valued at
$182k
|
|
05/22/2019 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns:
| Granted 19,000 options to buy
@ $15.78, valued at
$299.8k
|
|
11/26/2018 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Goldman Sachs Private Markets Fund 2018 (B) LLC |
11/26/2018 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Goldman Sachs Private Markets Fund 2018 (A) LLC |
11/26/2018 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Goldman Sachs Private Markets Fund 2018 LLC |
06/14/2018 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 880 shares
@ $0 |
|
05/24/2018 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Paid exercise price by delivering 922 shares
@ $270.8, valued at
$249.7k
Granted 1,473 shares
@ $0 |
|
05/21/2018 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns:
| Granted 19,000 options to buy
@ $25.98, valued at
$493.6k
|
|
|